S'abonner

COPD prevalence in a north-eastern Italian general population - 30/07/15

Doi : 10.1016/j.rmed.2015.05.009 
Massimo Guerriero a , Marco Caminati b, , Giovanni Viegi c, d , Gianenrico Senna b , Giancarlo Cesana e , Carlo Pomari f
a Department of Computer Science, University of Verona, Strada Le Grazie 15, 37134 Verona, Italy 
b Allergy Unit, Verona University and General Hospital, Piazzale Stefani 1, 37126 Verona, Italy 
c Institutes of Biomedicine and Molecular Immunology “Alberto Monroy” (IBIM), CNR, Via Ugo La Malfa 153, 90146 Palermo, Italy 
d Clinical Physiology (IFC), CNR, Via Trieste 41, 56123 Pisa, Italy 
e Department of Statistic and Quantitative Methods, University of Milano Bicocca, Via Bicocca Degli Arcimboldi 8, 20126 Milano, Italy 
f Pulmonary Unit, Sacro Cuore – Don Calabria Hospital, Via Don A. Sempreboni, 5, 37024 Negrar, Verona, Italy 

Corresponding author.

Summary

Background

COPD prevalence estimates vary mostly depending on different study methodologies. We evaluated the prevalence and clinical features of COPD, as defined by GOLD and ERS/ATS recommendations in a representative sample of Northern Italy general population.

Methods

A randomized cross-sectional study was performed. The study participants completed a questionnaire covering: key indicators for considering a diagnosis of COPD, self-reported physician diagnoses of respiratory disease, pharmacological treatment for respiratory disease, indirect costs, occupational and environmental exposures. They also underwent spirometry and physician assessment.

Results

We evaluated 1236 subjects. Daily respiratory symptoms were experienced by 26.7%. Of this group, only 30.7% had previously performed a spirometry. The overall COPD prevalence was: 11.7% according to GOLD criterion; 9.1% according to LLN criterion; 6.8% according to self-reported physician diagnosis. Of note, 48,8% of subjects with a reported diagnosis of COPD had never undergone a spirometry before the study.

Conclusions

Our study provides an estimation of COPD prevalence in a representative sample of Northern Italy general population relying on both clinical symptoms and spirometry outcomes, and describes the different prevalence rates depending on the adopted diagnostic criterion. Spirometry underuse may account for under-diagnosis and misdiagnosis of COPD. It may result in a major impact on quality of life as well as in economic burden.

Le texte complet de cet article est disponible en PDF.

Keywords : GLI 2012, LLN, Prevalence, Respiratory symptoms, Airflow limitation


Plan


© 2015  Elsevier Ltd. Tous droits réservés.
Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 109 - N° 8

P. 1040-1047 - août 2015 Retour au numéro
Article précédent Article précédent
  • Indacaterol vs tiotropium in COPD patients classified as GOLD A and B
  • Donald A. Mahler, Huib A.M. Kerstjens, James F. Donohue, Roland Buhl, David Lawrence, Pablo Altman
| Article suivant Article suivant
  • Physical activity and fatigue in chronic obstructive pulmonary disease – A population based study
  • Mikael Andersson, Caroline Stridsman, Eva Rönmark, Anne Lindberg, Margareta Emtner

Déjà abonné à cette revue ?